Abstract
Changes in thyroid status are associated with profound alterations in biochemical and physiological functioning of cardiac muscle impacting metabolic rate, contractility and structural hypertrophy. Using an in vivo model of chronic treatment with thyroid hormone (T4, 0.3 mg/kg/day), we evaluated how mitochondria are regulated in response to T4, and assessed the relationship of T4-induced mitochondrial biogenesis and bioenergetics to overall cardiac hypertrophy. The role of thyroid hormone in cardiac bioenergetic remodeling was addressed in rats treated with T4 for 5, 10 and 15 days. Over that time, myocardial oxygen consumption substantially increased as did cardiac hypertrophy. Myocardial levels of mitochondrial enzyme activities, mitochondrial DNA (mtDNA), specific proteins and transcript were assessed. Activity levels of respiratory complexes I-V and citrate synthase significantly increased with 15 but not with 5 or 10-day T4 treatment. Myocardial levels of mtDNA, mitochondrial proteins (e.g. cytochrome c, cytochrome b, ATPase subunits, MnSOD) and the global transcription factor PPARα were significantly elevated with 15-day T4. Transcript analysis revealed increased expression of transcription factors and cofactors involved in mitochondrial biogenesis including PPARα, mtTFA, ErbAα and PGC-1α. Our findings indicate parallel increases in myocardial mitochondrial bioenergetic capacity, oxygen consumption and markers of mitochondrial biogenesis with 15-day T4; these changes were not present with 10-day T4 even with significant cardiac hypertrophy. The marked, parallel increases in PPARα levels suggest its potential involvement in mediating myocardial-specific remodeling of mitochondria in response to T4. (Mol Cell Biochem xxx: 97–106, 2004)
Similar content being viewed by others
References
Brand MD, Murphy MP: Control of electron flux through the respiratory chain in mitochondria and cells. Biol Rev Camb Philos Soc 62: 141–193, 1987
Horst C, Rokos H, Seitz HJ: Rapid stimulation of hepatic oxygen consumption by 3,5-di-iodo-L-thyronine. Biochem J 261: 945–950, 1989
Szabo J, Nosztray K, Takacs I, Szegi J: Thyroxine-induced cardiomegaly: Assessment of nucleic acid, protein content and myosin ATPase of rat heart. Acta Physiol Acad Sci Hung 54: 69–79, 1979
Talafih K, Briden KL, Weiss HR: Thyroxine-induced hypertrophy of the rabbit heart. Effect on regional oxygen extraction, flow, and oxygen consumption. Circ Res 52: 272–279, 1983
Zhu NH, Weiss HR: Oxy-and carboxyhemoglobin saturation determination in frozen small vessels. Am J Physiol 260: H626–H6231, 1991
Marin-Garcia J, Ananthakrishnan R, Goldenthal MJ: Heart mitochon-drial DNA and enzyme changes during early human development. Mol Cell Biochem 210: 47–52, 2000
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254, 1976
Tanaka T, Morita H, Koide H, Kawamura K, Takatsu T: Biochemical and morphological study of cardiac hypertrophy. Effects of thyroxine on enzyme activities in the rat myocardium. Basic Res Cardiol 80: 165–174, 1985
Cote C, Boulet D: The translation system of rat heart muscle mitochondria is stimulated following treatment with L-triiodothyronine. Biochem Biophys Res Commun 128: 11425–11433, 1985
Gross NJ: Control of mitochondrial turnover under the influence of thyroid hormone. J Cell Biol 48: 29–40, 1971
Nishiki K, Erecinska M, Wilson DF, Cooper S: Evaluation of oxidative phosphorylation in hearts from euthyroid, hypothyroid, and hyperthyroid rats. Am J Physiol 235: C212–C219, 1978
Paradies G, Ruggiero FM, Petrosillo G, Quagliariello E: Enhanced cytochrome oxidase activity and modification of lipids in heart mito-chondria from hyperthyroid rats. Biochim Biophys Acta 1225: 165–170, 1994
Wrutniak-Cabello C, Casas F, and Cabello G: Thyroid hormone action in mitochondria. J Mol Endocrinol 26: 67–77, 2001
Nelson BD, Luciakova K, Li R, Betina S: The role of thyroid hormone and promoter diversity in the regulation of nuclear encoded mitochondrial proteins. Biochim Biophys Acta 1271: 85–91, 1995
Scarpulla RC: Nuclear activators and coactivators in mammalian mito-chondrial biogenesis. Biochim Biophys Acta 1576: 1–14, 2002
Cai Y, Nelson BD, Li R, Luciakova K, Depierre JW: Thyromimetic action of the peroxisome proliferators clofibrate, perfluorooctanoic acid, and acetylsalicylic acid includes changes in mRNA levels for certain genes involved in mitochondrial biogenesis. Arch Biochem Biophys 325: 107–112, 1996
Gilde AJ, Van Der Lee KA, Willemsen PH, Chinetti G, Van Der Leij FR, Van Der Vusse GJ, Staels B, Van Bilsen M: Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism. Circ Res 92: 518–524, 2003
Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, Spiegelman BM: Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98: 115–124, 1999
Hertz R, Nikodem V, Ben-Ishai A, Berman I, Bar-Tana J: Thyromimetic mode of action of peroxisome proliferators: Activation of 'malic' enzyme gene transcription. Biochem J 319: 241–248, 1996
Casas F, Rochard P, Rodier A, Cassar-Malek I, Marchal-Victorion S, Wiesner RJ, Cabello G, Wrutniak C: A variant form of the nuclear tri-iodothyronine receptor c-ErbAalpha1 plays a direct role in regulation of mitochondrial RNA synthesis. Mol Cell Biol 19: 7913–7924, 1999
Enriquez JA, Fernandez-Silva P, Garrido-Perez N, Lopez-Perez MJ, Perez-Martos A, Montoya J: Direct regulation of mitochondrial RNA synthesis by thyroid hormone. Mol Cell Biol 19: 657–670, 1999
Irrcher I, Adhihetty PJ, Sheehan T, Joseph AM, Hood DA: PPARgamma coactivator-1alpha expression during thyroid hormone-and contractile activity-induced mitochondrial adaptations. Am J Physiol Cell Physiol 284: C1669–C1677, 2003
Barger PM, Brandt JM, Leone TC, Weinheimer CJ, Kelly DP: Deactiva-tion of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth. J Clin Invest 105: 1723–1730, 2000
Dummler K, Muller S, Seitz HJ: Regulation of adenine nucleotide translocase and glycerol 3-phosphate dehydrogenase expression by thy-roid hormones in different rat tissues. Biochem J 317: 913–918, 1996
Schonfeld P, Wieckowski MR, Wojtczak L: Long-chain fatty acid-promoted swelling of mitochondria: Further evidence for the protonophoric effect of fatty acids in the inner mitochondrial membrane. FEBS Lett 471: 108–112, 2000
Portman MA:The adenine nucleotide translocator: Regulation and func-tion during myocardial development and hypertrophy. Clin Exp Phar-macol Physiol 29: 334–338, 2002
Young ME, Patil S, Ying J, Depre C, Ahuja HS, Shipley GL, Stepkowski SM, Davies PJ, Taegtmeyer H: Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart. FASEB J 15: 833–845, 2001
Barbe P, Larrouy D, Boulanger C, Chevillotte E, Viguerie N, Thalamas C, Trastoy MO, Roques M, Vidal H, Langin D: Triiodothyronine-mediated up-regulation of UCP2 and UCP3 mRNAexpression in human skeletal muscle without coordinated induction of mitochondrial respi-ratory chain genes. FASEB J 15: 13–15, 2001
Boehm EA, Jones BE, Radda GK, Veech RL, Clarke K: Increased uncoupling proteins and decreased efficiency in palmitate-perfused hyper-thyroid rat heart. Am J Physiol Heart Circ Physiol 280: H977–H983, 2001
Garstka HL, Facke M, Escribano JR, Wiesner RJ: Stoichiometry of mito-chondrial transcripts and regulation of gene expression by mitochondrial transcription factor A. Biochem Biophys Res Commun 200: 619–626, 1994
Virbasius JV, Scarpulla RC: The rat cytochrome c oxidase subunit IV gene family: Tissue-specific and hormonal differences in subunit IV and-cytochrome c mRNA expression. Nucleic Acids Res 18: 6581–6586, 1990
Seiden D, Navidad P, Weiss HR: Oxygen diffusion distance in thyroxine-induced hypertrophic rabbit myocardium. J Mol Cell Cardiol 20: 917–930, 1988
Lebuffe G, Schumacker PT, Shao ZH, Anderson T, Iwase H, Vanden Hoek TL: ROS and NO trigger early preconditioning: Relationship to mitoKATP channel. Am J Physiol Heart Circ Physiol 284: H299–H308, 2003
Asayama K, Dobashi K, Hayashibe H, Megata Y, Kato K: Lipid peroxidation and free radical scavengers in thyroid dysfunction in the rat: A possible mechanism of injury to heart and skeletal muscle in hyperthy-roidism. Endocrinology 121: 2112–2118, 1987
Lopez-Torres M, Romero M, Barja G: Effect of thyroid hormones on mitochondrial oxygen free radical production and DNA oxidative damage in the rat heart. Mol Cell Endocrinol 168: 127–134, 2000
Venditti P, Agnisola C, Di Meo S: Effect of ischemia-reperfusion on heart mitochondria from hyperthyroid rats. Cardiovasc Res 56: 76–85, 2002
Soboll S: Long-term and short-term changes in mitochondrial parameters by thyroid hormones. Biochem Soc Trans 21: 799–803, 1993
Das AM, Harris DA: Control of mitochondrial ATP synthase in rat cardiomyocytes: Effects of thyroid hormone. Biochim Biophys Acta 1096: 284–290, 1991
McCormack JG, Halestrap AP, Denton RM: Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol Rev 70: 391–425, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goldenthal, M.J., Weiss, H.R. & Marín-García, J. Bioenergetic remodeling of heart mitochondria by thyroid hormone. Mol Cell Biochem 265, 97–106 (2004). https://doi.org/10.1023/B:MCBI.0000044321.17680.a2
Issue Date:
DOI: https://doi.org/10.1023/B:MCBI.0000044321.17680.a2